Project Details
Description
A Multicenter, Randomized, Double-blind, Placebo controlled, Phase 2 Study Evaluating the Safety and Efficacy of Different Doses of IW-1973 over 12 Weeks in Patients with Heart Failure with Preserved Ejection Fraction (CAPACITY HFpEF)
Status | Finished |
---|---|
Effective start/end date | 1/1/18 → 1/30/21 |
Funding
- IRONWOOD PHARMACEUTICALS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.